BCT 194
/ Novartis
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 21, 2012
Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients
(clinicaltrials.gov)
- P1; N=12; Completed; Sponsor: Novartis Pharmaceuticals
Clinical • New P1 trial • Dermatology • Immunology • Psoriasis • TNFA
1 to 1
Of
1
Go to page
1